You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 8, 2025

Details for Patent: 8,993,520


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 8,993,520 protect, and when does it expire?

Patent 8,993,520 protects AXIRON and is included in one NDA.

This patent has twenty patent family members in thirteen countries.

Summary for Patent: 8,993,520
Title:Method and composition for transdermal drug delivery
Abstract: The invention is directed to a transdermal drug delivery composition which includes at least one physiologically active agent; and at least one volatile solvent; and at least one viscosity modulating agent. The invention extends to methods of administering such a composition to a subject and treatment of subjects using the composition.
Inventor(s): Dipietro; Tony (Victoria, AU), Humberstone; Andrew (Victoria, AU), Gonda; Igor (South Yarra, AU), Watkinson; Adam (Victoria, AU), Setiawan; Kerrie (Victoria, AU), Wilkins; Nina (Victoria, AU)
Assignee: Acrux DDS Pty Ltd (West Melbourne, Victoria, AU)
Application Number:12/823,448
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 8,993,520
Patent Claim Types:
see list of patent claims
Use; Composition; Delivery; Device;
Patent landscape, scope, and claims:

United States Patent 8,993,520: A Detailed Analysis of Scope, Claims, and Patent Landscape

Introduction

The United States Patent 8,993,520, titled "Method and composition for transdermal drug delivery," is a significant patent in the field of pharmaceuticals and drug delivery systems. This analysis will delve into the scope, claims, and the broader patent landscape surrounding this invention.

Patent Overview

Publication Details

  • Publication Number: US8993520B2
  • Filing Date: December 22, 2010
  • Grant Date: April 7, 2015
  • Assignee: Not specified in the provided sources, but typically found in the patent document itself[4].

Invention Description

The patent describes a method and composition for transdermal drug delivery. The composition includes at least one physiologically active agent and at least one volatile solvent. The invention is designed to enhance the delivery of active agents through the skin, using components such as penetration enhancers, viscosity modulating agents, and solvents like lower alkyl alcohols[4].

Scope of the Patent

Claim Structure

The patent includes multiple claims that define the scope of the invention. Here are some key aspects:

  • Independent Claims: These claims define the broadest scope of the invention. For example, Claim 1 might describe the composition and method in general terms, while subsequent claims narrow down specific components or methods[4].
  • Dependent Claims: These claims build upon the independent claims, adding additional limitations or specifics. For instance, a dependent claim might specify the type of penetration enhancer or the concentration of the solvent[4].

Metrics for Measuring Scope

Research suggests that patent scope can be measured using metrics such as independent claim length and independent claim count. Patents with narrower claims at publication tend to have a higher probability of grant and a shorter examination process[3].

Claims Analysis

Key Components

  • Physiologically Active Agent: The patent specifies that the composition includes at least one active agent, such as testosterone, which is delivered systemically through the skin[4].
  • Volatile Solvent: The solvent is crucial for facilitating the delivery of the active agent. Examples include ethanol, isopropanol, and acetone[4].
  • Penetration Enhancer: Components like octyl dimethyl-para-aminobenzoate, octyl para-methoxycinnamate, and octisalate are used to enhance skin penetration[4].
  • Viscosity Modulating Agent: This agent, such as a gelling or thickening agent, helps in maintaining the composition's viscosity[4].

Claim Examples

  • Claim 1: This might broadly describe the composition and method for transdermal drug delivery.
  • Claim 2: This could specify the use of a particular penetration enhancer.
  • Claim 3: This might detail the concentration range of the volatile solvent.

Patent Landscape

Related Patents and Applications

The patent landscape for transdermal drug delivery is extensive, with numerous patents and applications filed globally. Here are some key points:

  • Global Dossier: This service allows users to view the patent family for a specific application, including related applications filed at participating IP Offices. This can help in understanding the broader landscape and potential overlaps or conflicts[1].
  • International Patent Offices: Databases from the European Patent Office (EPO), Japan Patent Office (JPO), World Intellectual Property Organization (WIPO), and others provide access to international patent applications and granted patents in this field[1].

Litigation and Enforcement

Patents like US8993520B2 can be involved in litigation, particularly if there are claims of infringement or validity disputes.

  • Declaratory Judgment Claims: There have been cases where declaratory judgment claims arose under U.S. patent laws related to this patent, indicating potential disputes over its validity or infringement[5].

Search and Analysis Tools

USPTO Resources

  • Patent Public Search: This tool provides enhanced access to prior art and is essential for conducting thorough searches related to this patent[1].
  • Patent and Trademark Resource Centers (PTRCs): These centers offer local search resources and training in patent search techniques, which can be invaluable for analyzing the scope and claims of this patent[1].

International Resources

  • European Patent Office (EPO): The esp@cenet network provides access to Europe's patent databases, including machine translations for some languages[1].
  • World Intellectual Property Organization (WIPO): The PATENTSCOPE® Search Service offers full-text search capabilities for international patent applications and machine translations for some documents[1].

Impact on Innovation

Patent Quality and Scope

The scope and claims of a patent like US8993520B2 can significantly impact innovation in the field. Narrower claims tend to be associated with a higher probability of grant and shorter examination processes, which can encourage more focused and effective innovation[3].

Licensing and Litigation

Overly broad patents can lead to increased licensing and litigation costs, potentially diminishing incentives for innovation. The specificity and clarity of the claims in this patent are crucial in avoiding such issues[3].

Key Takeaways

  • Specific Claims: The patent includes detailed claims about the composition and method for transdermal drug delivery, which define its scope.
  • Global Landscape: The patent is part of a broader global landscape of transdermal drug delivery patents and applications.
  • Litigation Potential: The patent has been involved in litigation, highlighting the importance of clear and specific claims.
  • Innovation Impact: The scope and clarity of the claims can influence innovation and the overall efficiency of the patent system.

FAQs

What is the main invention described in US8993520B2?

The main invention is a method and composition for transdermal drug delivery, including a physiologically active agent and a volatile solvent.

What are the key components of the composition?

The key components include a physiologically active agent, a volatile solvent, a penetration enhancer, and a viscosity modulating agent.

How can one search for related patents globally?

One can use resources like the Global Dossier, European Patent Office (EPO) databases, Japan Patent Office (JPO) databases, and the World Intellectual Property Organization (WIPO) PATENTSCOPE® Search Service.

What metrics can be used to measure patent scope?

Metrics such as independent claim length and independent claim count can be used to measure patent scope and assess its impact on the examination process and innovation.

Why is the specificity of claims important in patents?

The specificity of claims is important because it affects the patent's validity, the likelihood of grant, and the potential for litigation and licensing issues, all of which can impact innovation.

Sources

  1. USPTO - Search for patents
  2. UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF ...
  3. Patent Claims and Patent Scope - Search eLibrary :: SSRN
  4. Method and composition for transdermal drug delivery - Google Patents
  5. in the united states district court

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,993,520

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Eli Lilly And Co AXIRON testosterone SOLUTION, METERED;TRANSDERMAL 022504-001 Nov 23, 2010 DISCN Yes No ⤷  Subscribe ⤷  Subscribe A METHOD OF INCREASING THE TESTOSTERONE BLOOD LEVEL OF AN ADULT MALE SUBJECT IN NEED THEREOF ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 8,993,520

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Australia2005902902Jun 3, 2005

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.